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Genome-modiﬁcation technologies enable the rational
engineering and perturbation of biological systems. His-
torically, these methods have been limited to gene inser-
tions or mutations at random or at a few pre-deﬁned
locations across the genome. The handful of methods
capable of targeted gene editing suffered from low efﬁcien-
cies, signiﬁcant labor costs, or both. Recent advances
have dramatically expanded our ability to engineer cells
in a directed and combinatorial manner. Here, we review
current technologies and methodologies for genome-scale
engineering, discuss the prospects for extending efﬁcient
genome modiﬁcation to new hosts, and explore the
implications of continued advances toward the develop-
ment of ﬂexibly programmable chasses, novel biochemis-
tries, and safer organismal and ecological engineering.
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Introduction
The phrase ‘genome-scale engineering’ invokes a future in
which organisms are custom designed to serve humanity. Yet
humans have sculpted the genomes of domesticated plants
and animals for generations. Darwin’s contemporary William
Youatt described selective breeding as ‘that which enables the
agriculturalist, not only to modify the character of his ﬂock,
butto change italtogether.It isthe magician’swand,bymeans
of which he maysummon into life whatever form and mold he
pleases’ (Youatt, 1837). Selective breeding has transformed
aurochs into Holsteins, wolves into Chihuahuas and Great
Danes, and teosinte into maize. All of these examples involved
genomic changes at a scale dwarﬁng any attempted through
rational design. Understanding why genomes have been more
readily shaped by evolutionary principles than conventional
design-based approaches is important for current and future
genome engineering endeavors.
Engineering is a human enterprise consisting of iterative
cycles of design, construction, and testing. Optimizing this
iterativeprocessinvolvesbalancingtherelativetime,costs,and
expected beneﬁts gained at each phase. However, rationally
designing and building a genome to produce the desired
phenotype has proven exceedingly difﬁcult. Designing organ-
isms to speciﬁcation requires accurately predicting phenotype
from genotype, a complex problem that is worsened by our
incomplete knowledge of biomolecule production, degrada-
tion, and interaction rates. Moreover, the computational
resources required to run bottom-up molecular-level simula-
tions are daunting even for simpler systems (Karr et al, 2012;
Koch, 2012). Nevertheless, models have been useful for
generating new hypotheses and targeting promising areas for
engineering.Yet,evenwith the best insilicopredictions, we are
still limited by our ability to construct the designed genome.
More than any other factor, the absence of molecular tools for
manipulating genomic sequences has forced us to rely on
selectivebreedingandevolutionaryoptimization(Conradetal,
2011) rather than rational genome design.
Recent breakthroughsin genomics and genomeediting have
promised a greater role for rational design in biological
engineering (Figure 1), offering new opportunities for systems
and synthetic biologists aiming to reverse-engineer naturally
evolved systems and to build new systems. In particular,
advances in high-throughput DNA sequencing and large-scale
biomolecular modeling of metabolic and signaling networks
represent two important new frontiers that aid genome-scale
engineering. Over the last few years, thousands of bacterial
genomes have been sequenced from a wide variety of natural
species and numerous laboratory-generated strains (Pagani
et al, 2012). These efforts have illuminated many essential
features of the core genome (Lukjancenko et al, 2010), the
extent and importance of genetic heterogeneity across
populations (Avery, 2006), the ubiquity of horizontal gene
transfer (Smillie et al, 2011), and the evolution and selection of
functional genetic elements (David and Alm, 2011). At the
same time, new computational tools have used the ﬂood of
data to model metabolic processes and signaling networks
across the entire cell, generating many new testable hypoth-
eses (Lewis et al, 2012). Most importantly, emerging advances
in de novo synthesis and in vivo gene targeting allowempirical
validation of these model-driven hypotheses. By building and
testing synthetic variants of biological systems, we have a
unique opportunity to decipher the constraints imposed by
the complexity of evolved systems and develop strategies
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modeling and rational design.
Here we review recent technologies that empower design-
based genome engineering approaches, identify potential
bottlenecks, discuss strengths and limitations of strategies
employing rational design versus evolution, and consider
future applications of genome-scale engineering. We advocate
a synergistic engineering strategy that adopts the best aspects
of rational genome design and evolutionary optimization.
What is genome-scale engineering?
Genome engineering is the art of constructing a genotype
that gives rise to a desired phenotype, a challenge whose
difﬁculty is inﬂuenced by the scale of genomic alteration
required. One measure of scale is the number of changes that
must be made to an existing genome to produce the desired
phenotype. In some cases, this may require editing only one
gene, a task that is clearly not genome scale. The same is true
for a library of single-gene variants and even a complete
collection of single-gene knockouts (Giaever et al, 2002; Baba
et al, 2006), as each genome has only a single change. We
deﬁne genome-scale engineering to be anyendeavor involving
sequence modiﬁcations to at least two distinct regions of a
genome.Inwhatfollows,wewillmainlyfocusontechnologies
potentially capable of modifying large fractions of a single
genome.
Genome-scale engineering allows us to experimentally
probe deep biological questions such as essentiality (Koonin,
2000), epistasis (Chou et al, 2011; Khan et al, 2011), encoding
(Itzkovitz and Alon, 2007), evolvability (Tokuriki and Tawﬁk,
2009; Wagner and Zhang, 2011; Hill and Zhang, 2012), and
robustness (Bershtein et al, 2006). At the same time, we aim to
rationally build useful organisms that cannot be easily
generated by harnessing evolution alone. Such endeavors
require foundational tools in design, modeling, construction,
and testing that extend from individual cells to populations of
organisms (Figure 2). Iterations of design, model, build, and
test phases are likely to be more important as the scale of the
endeavor increases because biological complexity can grow
exponentially. Below, we describe key features of these phases
in genome-scale engineering, outline current capabilities, and
suggest opportunities for improvement.
Genome designs and models
Designisasetofspeciﬁcationsintendedtoachieveadedicated
objective under various constraints. Biological designs are
those that describe the underlying blueprint of living organ-
isms, built upon the information encoded in genes across the
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Figure 1 A historical timeline of selected advances leading to genome-scale engineering.
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individual genes to entiregenomes,thereis a growing need for
more sophisticated genome design tools to assist such large-
scale engineering endeavors. Recordkeeping software is
essential for tracking numerous modiﬁcations designed and
generated across libraries of genomes. Traditional gene editors
such as Vector NTI and SeqBuilder are largely inadequate
for such purposes. However, new design tools and software
suites such as J5 (Hillson et al, 2012), Clotho (Xia et al, 2011),
and Genome Compiler (http://www.genomecompiler.com/)
provide better data management and user interfaces for the
design of large operons and whole genomes.
Althoughrecordkeepingisimportant, itis onlyoneaspectof
design,whichmustcarefullydeﬁnetheexperimentalobjective
and triage candidate implementations according to likely
failure modes. The complexity of biological systems often
renders effective design a challenge. Fortunately, computa-
tional models can provide a useful guiding framework.
Constraint-based reconstruction and analysis (COBRA) mod-
els such as ﬂux-balance analysis have served as excellent
predictive tools improve designs. These models generally rely
on steady-state analysis of metabolic ﬂux to determine useful
genomic targets that optimize a desired phenotype in silico.
Although a detailed discussion of such models is beyond the
scope of this review, COBRA-based approaches have been
reviewed extensively elsewhere (Lewis et al, 2012).
Whereas specialized metabolic models have been used for
some years, Karr et al (2012) recently published the ﬁrst
complete virtual model of a cell, M. genitalium. At only B525
genes, M. genitalium is one of the smallest genomes known.
Nevertheless, its phenotype is determinedbythe interaction of
so many molecular components that it cannot be accurately
modeled using any single method. To surmount this problem,
Karr et al (2012) partitioned Mycoplasma into 28 distinct
modules, modeled each using the most appropriate represen-
tation, and integrated the results to describe the entire cell.
Analysis of unexpected behaviors on the part of the resulting
virtual cell led to novel hypotheses concerning emergent
controls on cellular behavior and identiﬁcation of promiscu-
ous enzyme activities capable of compensating for the lost
genes. Despite these successes, accurate genotype-to-pheno-
type predictions of multiple genomic perturbations are still
challenging due to biological complexity, large combinatorial
variations, and computational limitations. Nonetheless, these
examples demonstrate the power and utility of predictive
models in understanding cellular behavior and identifying
promising biological designs.
A complementary alternative to in silico prediction is direct
experimental perturbation to identify potential targets and
failure modes. Recent breakthroughs combining large-scale
mutagenesis with DNA sequencing have contributed signiﬁ-
cantly to improved genomic designs. Hutchison et al (1999)
showed that sequencing transposon-generated libraries of
mutants can be used to systematically identify essential genes
within theMycoplasmagenome.Morerecentapproacheshave
employed next-generation sequencing, including Insertion
Sequencing (IN-Seq) (Goodman et al, 2011), transposon
sequencing (Tn-seq) (van Opijnen et al, 2009), high-through-
put insertion tracking by deep sequencing (Wong et al, 2011),
and transposon-directed insertion-site sequencing (Eckert
et al, 2011). IN-Seq, for example, involves the generation of
libraries by random insertion of a Himar1 transposon contain-
ing a modiﬁed inverted repeat (IR) sequence. This IR is also
recognized by the Type IIS restriction enzyme MmeI, which
cuts the DNA 17 bases outside of its recognition site. When
digested in vitro, genomic DNA carrying transposons harbor-
ing MmeI sites will generate fragments that include an extra
16–17bp of genomic DNA, allowing high-throughput sequen-
cing to pinpoint the locations of all insertions. By enabling
researchers to compare the abundance of individual mutants
in the library before and after an experimental perturbation,
Tn-seq techniques enable multiplexed functional analysis of
entire genomes. Every gene essential for the survival of a
species can be identiﬁed in a single experiment that
simultaneously rank-orders all nonessential ‘accessory’
genes by their relative importance to organismal ﬁtness
under the conditions of interest. Other approaches such as
global transcription machinery engineering (Alper and
Stephanopoulos, 2007) and genome-scale proﬁling of bar-
coded mutant libraries (Warner et al, 2010) can have a similar
role in informing design. Expansion and broader adoption of
thesemethodstoguidegenome-scaledesignisneededforboth
single-cell and multicellular organisms.
An expanding toolbox for genome
construction and manipulation
A wide variety of tools for targeted gene disruption and
transgenesis are currently available (Figure 3). These tools
Design
Genome editors
and compilers
Build
MAGE, CAGE,
de novo synthesis,
in vitro transplantation
Test
Multiplexed
whole cell/population
assays
Model
Multi-cellular
models
In silico In vitro and in vivo
Single site,
single genome
Many sites,
many genomes
I
n
c
r
e
a
s
i
n
g
s
c
a
l
e
 
a
n
d
 
s
c
o
p
e
Genome
engineering
Gene and
operon editors
Recombinases,
ZF/TAL effectors,
CRISPR
Phenotypic assays,
genome sequencing,
transcriptomics
Metabolic and
cellular models
Figure 2 Foundational genome engineering tools and approaches are needed to extend single site genetic perturbations of a single genome to multiple changes
across many genomes.
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retargeting, and effectiveness across a variety of different
organisms (Table I). We focus on those with the greatest
potential to enable large-scale changes to single or multiple
genomes by replacing large contiguous sequences or modify-
ing numerous smaller sites serially or in parallel.
Targeted genome engineering
Recombinases
Because delivering large genetic constructs into many cell
types is difﬁcult, highly efﬁcient methods of recombining the
host genome with an introduced construct are useful for
applications requiring large amounts of foreign DNA or the
replacement of many contiguous genes with modiﬁed or
synthetic variants. Recombinases are DNA-binding enzymes
that catalyze highly speciﬁc and efﬁcient DNA splicing
reactions between two sites. Early experiments with phage-
derived recombinases irreversibly incorporated circular
constructs containing the phage attP site into the attB site of
thehostgenomenormallyutilizedbythephage(Mizuuchiand
Mizuuchi, 1980). Later work demonstrated that these ‘inte-
grases’ can perform a similar role in a wide variety of species
if the appropriate attB or attP target site is inserted into
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Figure 3 Mechanisms of various targeted genome-modiﬁcation tools. Integrases can insert a circular donor construct into a recognition site on the genome.
Recombinase-mediated cassette exchange (RMCE) involves the replacement of a target sequence ﬂanked with recognition sites with a donor cassette ﬂanked by
compatible sites. Homologous recombination using double-stranded DNA cassettes enables programmable target replacement using RecA or RecET-like machinery,
which can be stimulated via site-speciﬁc cleavage using zinc-ﬁnger, CRISPR, or TAL nucleases. Group II introns and insertional elements can be designed to insert into
site-speciﬁc genome targets. Oligo-mediated allelic replacement incorporates short oligonucleotides into the lagging strand of replicating DNA, which are then resolved
upon subsequent cell divisions to inherit the designed mutation.
Table I Comparison of various targeted genome engineering methods
Class System Programmable Efﬁciency Multiplexable Examples Organism
Protein site-speciﬁcity Integrase Limited High No l-int, fC31 B, P, M
Recombinase Limited High No Cre, Flp, RMCE B, P, M
Zinc-ﬁnger Moderate Variable Maybe ZF-FokI, ZF-Tn3 B, P, M
TAL effector Moderate/High Variable Maybe TAL-FokI B, P, M
Nucleic acid site-speciﬁcity Retro-transposon Moderate Variable Maybe Ll.LtrB intron B
dsDNA
Homol. recomb.
High Low No l-Red, RecET (B, M)
ssDNA
Homol. recomb.
High High Yes Redb, RecT (B, M)
CRISPR/Cas High Variable Maybe Cas9 B, M
De novo synthesis Variable High N/R N/R M. mycoides B, M
Abbreviations: B, bacteria; M, metazoan; N/R, not relevant; P, plants; (), has not worked in all species tested.
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alternatively utilize ‘pseudo-att’ sites native to the genome at
somewhat lower efﬁciency (Thyagarajan et al, 2001). Cre
recombinase, originally from phage P1 (Sternberg et al, 1981),
is the gold standard for efﬁcient recombination of target sites
across a wide variety of species. However, its comparative
promiscuityleadstotoxicityinsomeeukaryotes,leadingtothe
development of Flp recombinase as an alternative (Turan et al,
2011). Unlike integrases, Cre and Flp are reversible enzymes
that normally recombine two identical recognition sites to
invert or excise the intervening sequence, but they can be
made irreversible by utilizing ‘poisoned’ half-sites that
generate an inactive site upon recombination (Schlake and
Bode, 1994; Albert et al, 1995).
In the context of genome-scale engineering, recombinases
are most useful for efﬁciently inserting large DNA constructs
into the genome. By ﬂanking an endogenous sequence with
orthogonal recognition sites from two different recombinases
or two orthogonal sites recognized by the same recombinase,
the sequence may be replaced by a synthetic donor construct
containing compatible sites (Schlake and Bode, 1994; Missirlis
et al, 2006; Sheren et al, 2007). With three pairs of orthogonal
sites, this technique could conceivably be used to iteratively
insert large cassettes into the genomes of many different
organisms ad inﬁnitum (Turan et al, 2011; Obayashi et al,
2012).Unfortunately,recombinasesrequirepre-existingrecog-
nition sites, which must be introduced to the target site by
another method. Although directed evolution methods have
yielded recombinases capable of recognizing alternative sites
(Buchholz and Stewart, 2001; Sarkar et al, 2007), such
approaches are presently too laborious for most laboratories.
New methods of performing directed evolution may relax this
limitation (Esvelt et al, 2011). A promising design-based
alternative involves replacing the native DNA-binding domain
withanexogenousdomainthatcanbemoreeasilyengineeredto
target a sequence of interest (Akopian et al, 2003). Although
the resulting chimeric enzymes are highly speciﬁc, they are
currently inefﬁcient compared with natural recombinases
(Gordley etal, 2009).It is likely that extensive directedevolution
will be required to render the catalytic domain suitable for
retargeting by replacement of the DNA-binding domain.
Zinc-ﬁnger nucleases and TAL effector nucleases
Targeted genome engineering requires a means of speciﬁcally
recognizing the sequence of each site to be modiﬁed.
Zinc-ﬁngers (ZFs) and TAL (transcription activator-like)
effectors are a class of versatile and programmable
DNA-binding proteins that have enabled effector proteins,
including DNA-modifying enzymes, to be targeted to speciﬁc
sequences in a variety of organisms. ZFs are stackable motifs
of B30 amino acids that recognize approximately three base
pairs of DNA with varying speciﬁcity. Although ZFs recogniz-
ing each triplet cannot be simply stacked to reliably recognize
longer sequences (Ramirez et al, 2008), a variety of design
(Sander et al, 2011b) and selection-based (Maeder et al, 2009)
methods are capable of generating speciﬁc DNA binders.
Unfortunately, custom ZFs remain relatively difﬁcult and
expensivetoobtainforthetypicallaboratory.DNArecognition
by TAL effector domains is more straightforward, with each
34-aaTALmotifrecognizingasinglebasepairthroughcontacts
with amino acids 12 and 13, known as the repeat variable
di-residue (RVD) (Boch et al, 2009). Unlike ZFs, TAL effectors
are readily stacked to recognize long sequences. Although the
assembly of TALs is complicated by their larger size and
abundant repeat regions, a number of recently described
approaches have the potential to overcome these challenges
(Weber et al, 2011; Briggs et al, 2012; Reyon et al, 2012).
ZF and TAL nucleases (ZFNs and TALENs) are created by
coupling a ZF or TAL DNA-binding domain to the nonspeciﬁc
nuclease domain of the FokI restriction enzyme. When two
monomers bind to adjacent sites, their FokI domains dimerize
and catalyze DNA cleavage, causing a double-strand break
(DSB) (Kim et al, 1996). DSBs are most commonly repaired
by homologous recombination (HR) or non-homologous
end-joining (NHEJ). ZFN cleavage followed by HR with a
donorsequencecontaininghomologousﬂankingregionsleads
to insertion of the donor sequence at efﬁciencies of B1–15%
(Urnov et al, 2005), while ZFN cleavage followed by error-
prone NHEJ results in gene disruption from small deletions or
insertions, typically at somewhat higher efﬁciencies (Urnov
et al, 2010). Targeted gene editing using ZFNs has been
demonstrated in a variety of cell types, including ﬂies
(Bibikova et al, 2003), worms (Wood et al, 2011), sea urchins
(Ochiai et al, 2010), zebraﬁsh (Ekker, 2008), silkworms
(Takasu et al, 2010), frogs (Young et al, 2011), plants (Cai
et al, 2009; Osakabe et al, 2010; Zhang et al, 2010), and
numerous mammals (Urnov et al, 2005; Geurts et al, 2009;
Hauschild et al, 2011). Nuclease activity can be toxic in some
cell types, possibly due to off-target activity, but this problem
can be mitigated by utilizing less toxic ‘nickase’ variants that
cut only one strand (Kim et al, 2012; Ramirez et al, 2012).
Customized ZFNs are commercially available, although at a
signiﬁcant cost. TAL effector nucleases (TALENs) can more
readily target a variety of sequences by virtue of their more
ﬂexible RVD-based recognition. Although newer and less
thoroughly studied, TALENs appear to have fewer off-target
effects and lower toxicity than corresponding ZFNs
(Mussolino et al, 2011). Design tools are freely available
(Doyleetal,2012)withpredictedviablecleavagesitesevery35
basepairs in mammalian genomes on an average (Cermak
et al, 2011). Their primary weakness is the difﬁculty of
assembling and delivering such large and repeat-prone
sequences. TALENs have been successfully applied in numer-
ous organisms including yeast (Li et al, 2011), ﬂies (Liu et al,
2012), zebraﬁsh (Sander et al, 2011a), plants (Li et al, 2012),
rats (Tesson et al, 2011), and human cells (Hockemeyer et al,
2011) with gene disruption efﬁciencies of up to 25% (Miller
et al, 2011).
Group II intron retrotransposition
Certain group II introns are selﬁsh genetic elements that
undergo genomic transposition through an RNA intermediate.
Because targeting is determined primarily by base-pairing
interactions with the intron RNA, these site-speciﬁc
retrotransposons can be retargeted to accomplish both gene
disruption and gene insertion. The commercially available
Targetron system harnesses a retrotransposon capable of
inserting up to 1.8kb into the genome (Karberg et al, 2001).
Genome-scale engineering
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depending on the site and species (Perutka et al, 2004).
Sequences suitable for insertion are found every few hundred
bases on average, permitting most genes to be disrupted.
Moreover, the system is active in a wide variety of microbes,
providing genetic manipulation of species that cannot be
modiﬁed using other methods (Yao and Lambowitz, 2007).
Notably, insertions of recombinase recognition sites may
permit subsequent recombinase-mediated cassette exchange.
Targeting efﬁciency may be high enough to permit multiplex
modiﬁcations, though this has yet to be demonstrated.
Interestingly, group II introns can also be used to generate
DSBs (Karberg et al, 2001), suggesting a potential use in
promoting HR if they can be engineered or evolved to function
efﬁciently in eukaryotes.
Recombineering
Recombineering (or recombinogenic-engineering) uses a
phage-derived HR pathway to recombine a donor DNA strand
with a homologous sequence in the bacterial host. Given
sufﬁcient regions of ﬂanking homology (4500bp), endogen-
ous HR, which is usually mediated by the RecA/Rad51
pathway, is capable of integrating sequences into the genome
of almost any cell. However, low efﬁciency of the native HR
machinery limits the use of this technique without efﬁcient
DNA delivery and selection. Recombineering is an improved
approach that utilizes phage proteins (RecET, l-Red) to
dramatically increaseHRfrequenciesacross theentiregenome
(Zhang et al, 1998; Datsenko and Wanner, 2000; Yu et al,
2000). In E. coli,H Rb yl-Red is RecA-independent and instead
relies on three proteins: Exo, Beta, and Gam (Muyrers et al,
2000; Yu et al, 2000). Exo is a 50-30 exonuclease that digests
linear double-stranded DNA (dsDNA), leaving 30 single-
stranded intermediates that then act as substrates for
subsequent recombination (Maresca et al, 2010). Beta is a
single-stranded DNA (ssDNA)-binding protein that facilitates
recombination via hybridization of the linear fragment to its
genomic complement. Gam acts to inhibit RecBCD activity
in vivo to prevent the degradation of foreign linear dsDNA
fragments. Although recombineering still requires a selection
step, the l-Red-like system will function with as few as 40bp
of homology ﬂanking double-stranded donor DNA fragments
of up to several kilobases in length, a limit imposed by a
combination of the transformation and recombination efﬁ-
ciencies. Thus, simple PCR ampliﬁcation of a selectable
cassette (typically an antibiotic resistance or metabolic gene),
with primers containing ﬂanking homologous sequences to
the target site, enables limited rewriting of any region of the
genome (Sharan et al, 2009). A recent combinatorial example
of this technique, Trackable Multiplex Recombineering, used
primers derived from DNA microarrays to generate pools of
barcoded dsDNAcassettes that can target different sites across
thegenome (Warneret al, 2010). Short ssDNAcan alsobe used
in recombineering, a process which requires only the l-Beta
protein. We discuss the utility of such approaches for multi-
plexed recombineering in the next section. Although recombi-
neering systems have been developed for several model
bacteria (van Kessel and Hatfull, 2007; Swingle et al, 2010a;
van Pijkeren and Britton, 2012), more work is needed to
expand the methodology to other organisms. A search for
l-Red-like enzymes derived from phages and viruses that
infect other organisms is ongoing (Datta et al, 2008).
RNA-guided CRISPR nucleases
The nucleic acid-targeted CRISPR (Clustered Regularly Inter-
spaced Short Palindromic Repeat) system has great potential
for genome modiﬁcation in many organisms. CRISPR systems
defend bacteria and archaea from invading phage and
plasmids by RNA-directed degradation of DNA (Wiedenheft
etal,2012).InTypeIICRISPRsystems,theCas9proteinlocates
DNA ‘protospacer’ sequences homologous to the ‘spacer’
sequence in a guiding CRISPR RNA (crRNA) and checking for
sufﬁcient RNA–DNA base pairing (Jinek et al, 2012). Upon
identifying a matching sequence that also contains an
appropriate protospacer-adjacent motif (PAM), the enzyme
cleaves both DNA strands B3bp from the start of the PAM,
causing a DSB (Gasiunas et al, 2012). PAM sequences are quite
short (NGG (Deltcheva et al, 2011), NGGNG (Horvath et al,
2008), NNAGAAW (Deveau et al, 2008), and NAAR (van der
Ploeg, 2009) to date), permitting most sequences to be
targeted. At least 12bp of perfect homology, in addition to
the PAM, appears to be necessary for CRISPR endonuclease
activity (Deveau et al, 2008; Sapranauskas et al, 2011; Jinek
et al, 2012; Mali et al, 2013; Cong et al, 2013). In bacterial
CRISPR loci, the spacer regions of crRNAs are normally
ﬂanked by direct repeats of similar size that are critical for
recognition and processing by Cas9 and RNaseIII (Deltcheva
etal,2011),butsyntheticmimicsofthematurecrRNAfunction
equally well in vitro (Jinek et al, 2012).
We and others have recently demonstrated that Cas9 can be
used to engineer mammalian genomes (Mali et al, 2013; Cong
etal,2013).Cas9can bedirectedto cleaveanysequencewith a
compatible PAM—in these cases NGG—by expressing a
chimeric RNA mimic (Mali et al, 2013) or a spacer array
togetherwiththetracrRNArequiredforprocessing(Congetal,
2013). Gene modiﬁcation via DSB-stimulated HR is accom-
plished by simply expressing Cas9 and a cassette that
generates a RNA with a spacer matching the target sequence
in the desired cell. Targeting two adjacent sites effectively
deleted the intervening region, demonstrating limited but
multiplexed gene disruption capabilities. Knocking out one of
the two Cas9 nuclease domains converted the enzyme into a
nickase capable of stimulating HR with comparable efﬁciency
while reducing the frequency of NHEJ. Importantly, both
gene disruption and HR rates appear to be comparable to or
greater than those achieved with ZFNs and TALENs targeting
the same loci.
Interestingly, sustained Cas9 activity might be used to
simultaneously promote HR while selecting against cells
retaining the target region, potentially obviating the need for
positive selection markers. This approach would be feasible
in genomes engineered to constitutively express Cas9, which
could be subsequently edited by simply delivering the
appropriate donor cassette and crRNA. Further development
of CRISPR-mediated genome engineering technologies should
focus on increasing the speciﬁcity beyond the current 12bpþ
NGG sequence, which would likely lead to some unintended
off-target cutting, and on enabling genomic sequences with
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ease of use, Cas9-mediated gene targeting represents a new
and promising genome editing approach, especially in
mammalian systems.
Multiplexed genome engineering
The ability to edit single genes is an important step toward
engineering whole genomes. The explosion of modiﬁcations
achievedwithZFNsandTALENsareparticularlystrikinggiven
the dearth of prior alternatives for most multicellular organ-
isms. Still, the sheer size of even the smallest bacterial
genomes renders serial modiﬁcation of limited utility for
truly genome-scale engineering endeavors. Efﬁcient methods
enabling multiplex genome editing are urgently needed.
Unfortunately, techniques that generate DSBs to catalyze
homology-directed repair may be difﬁcult to multiplex due to
the toxicity of multiple simultaneous breaks and the high rate
of NHEJ, which could easily lead to unintended rearrange-
ments. High-efﬁciency ZF or TAL effector recombinases
represent one potential alternative, although quickly generat-
ing large numbers of ZFs or TALs presents an additional
challenge. Another option might involve fusing a nuclease-
inactivated Cas9 protein to the catalytic domain of a
recombinase, although retaining function could prove to be
difﬁcult. Group II introns may be multiplexable for gene
disruption, buttheyleaveunavoidablescarsites,are limitedto
small cargo capacities, and have not been demonstrated to
work efﬁciently in eukaryotes. Meanwhile, the low efﬁciency
ofdouble-strandedl-Red-mediatedrecombineeringalsolimits
its use for multiplexed genome-scale engineering. However,
l-Red-like proteins also facilitate recombination of smaller
ssDNA fragments. On the basis of prior work (Ellis et al,
2001), we recently described an approached known as
Multiplex Automated Genome Engineering (MAGE) that
utilizes short ssDNA oligonucleotides (oligos) instead of
dsDNA cassettes to mediate targeted genome modiﬁcation
(Wang and Church, 2011; Wang et al, 2009). Speciﬁcally,
oligos that are complementary to the lagging strand of
replicating genomes are incorporated into the daughter
genome at high efﬁciency, presumably by mimicking Okazaki
fragments at the replication fork (Yu et al, 2003). Oligos that
target the leading strand appear to have 450-fold lower
incorporation efﬁciency.
MAGE can precisely engineer any site in the genome by
simply introducing an oligo matching the desired sequence.
Oligosrangingfrom30to100basesareefﬁcientlyintegratedas
long as there are sufﬁcient homology arms to facilitate ssDNA
annealing to the target (Ellis et al, 2001). At the center of the
oligo, new sequences can be designed (up to 30 bases along a
90-base oligo) and introduced into the genome as a hetero-
duplex, which is resolved into fully mutated alleles during
subsequent rounds of cell division. In E. coli, oligo incorpora-
tion is increased 41000-fold by the ssDNA-binding protein
l-Beta. Removal of the endogenous mismatch repair machin-
ery (e.g., DmutS) (Costantino and Court, 2003) or evasion of
mismatchrepairthroughmodiﬁedbases(Wangetal,2011)can
signiﬁcantly increase the efﬁciency of oligo incorporation to
levels 430% per viable progeny (Wang et al, 2009). Use
of a co-selectable marker can further increase the efﬁciency to
470% (Carr et al, 2012; Wang et al, 2012b).
Several factors make the oligo-mediated MAGE approach
particularly attractive for genome-scale engineering. First, the
transformationefﬁciencyofshortoligosishighcomparedwith
plasmids or dsDNA cassettes, thereby allowing large pools of
oligos with different genomic targets to simultaneously enter
the cell and undergo incorporation. Because not all oligos are
incorporated in every cell, combinations of mutations are
generated through this process. With incorporation efﬁcien-
cies above 70%, cells containing 410 targeted mutations can
be isolated after a single transformation (Lajoie et al, 2012) by
simply screening 100 colonies with multiplex allele-speciﬁc
PCR (Wang and Church, 2011). Second, the protocol can be
iteratively repeated on a population of cells with only 2–3h of
recovery growth needed between cycles. Iterative cycling
enables further multiplexing and enrichment of mutants that
are otherwise found at low frequencies in the population,
which can be automated (Wang et al, 2009). Third, oligos can
be easily and cheaply synthesized using commercial vendors
and used directly in MAGE reactions without the need for
further processing, in contrast to dsDNA cassettes which
require additional steps of PCR ampliﬁcation and puriﬁcation.
Furthermore, high-density DNA microarrays can serve as
potential sources of large pools of unique DNA sequences to
extend multiplexed genome-scale engineering. Finally, oligo-
mediated genome engineering approaches such as MAGE
will likely function in a variety of organisms by virtue of
mechanistic simplicity. To date, oligo-mediated allelic replace-
ment has been demonstrated in Gram-negative bacteria
(Swingle et al, 2010b), Gram-positive bacteria (van Pijkeren
and Britton, 2012), and mammalian cells (Rios et al, 2012).
Semi-synthetic and synthetic genomes
Since the chemical synthesis of the ﬁrst gene in 1972 (Agarwal
et al, 1972), the cost of DNA synthesis has precipitously
decreasedasthe throughput hassoared,enabling construction
andassemblyofgenesandgenomesdenovo(CarrandChurch,
2009). Individual gene-sized DNA fragments are readily
synthesized commercially and assembled into larger operons
(Kodumal et al, 2004; Tian et al, 2009). Efforts to build phage
(Chan et al, 2005) and viral genomes (Blight et al, 2000;
Cello et al, 2002), chromosomal arms of S. cerevisiae (Dymond
et al, 2011), and, most impressively, the entire genome of
M. mycoides (Gibson et al, 2008) have been described.
New technologies enabling oligonucleotide synthesis on
DNA microarrays continue to reduce the cost and increase
the throughput for building synthetic genes and genomes
(Tian et al, 2004; Kosuri et al, 2010; Quan et al, 2011).
The question of when it is best to adopt an editing, semi-
synthetic,orsyntheticapproachtogenomeengineering hinges
on the reliability of design. Without the ability to accurately
evaluate large numbers of potential designs in silico, we must
build and test them empirically. Currently, large-scale de novo
synthesis of a genome requires a signiﬁcantly greater level of
resources and effort than directly editing an existing genome.
Consequently, a genome editing approach may be optimal
when generating genomes with a moderate degree of speciﬁed
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for tuning regulatory networks (Wang et al, 2009,2012b) or
altering protein sequences (Wang et al, 2012a). A de novo
synthesis approach is more likely to be appropriate for larger-
scale alterations such as codon optimization (Welch et al,
2009) or refactoring (Chan et al, 2005; Temme et al, 2012) that
are recalcitrant to genome editing technologies.
Building an entire synthetic genome can be difﬁcult to
troubleshoot, costly, and prone to failure. An illustrative
example of such issues was observed during the construction
of the synthetic 1.1Mb M. mycoides genome, when a single
basepair deletion in the essential gene dnaA prevented the
generation of a viable cell (Gibson et al, 2010). Only when
different synthetic pieces were swapped with natural
sequences did the researchers identify the source of the error,
highlighting the importance of direct testing. Underlying
design ﬂaws may be even more difﬁcult to assess as they
may impact the cell physiology in non-linear and epistatic
ways. Thus, step-wise construction and testing of progres-
sively modiﬁed intermediates will be a crucial approach for
most genome-scale engineering efforts until the failure rate of
engineered biological designs can be reduced to acceptable
levels. Consequently, methods capable of rapidly assembling
andexchangingindividuallysynthesizedand separatelytested
genome fragments will be needed. Current examples include
in vitro enzymatic assembly methods (Li and Elledge, 2007;
Engler et al, 2008; Gibson et al, 2009; Zhang et al, 2012)
and Conjugative Assembly Genome Engineering in vivo
(Isaacs et al, 2011) (Figure 4). Recent studies have already
described instances of cloned or hybrid genomes constructed
by transformation or assembly of a donor genome into a
recipient cell that retains its own genome. While the Bacillus-
Synechocystis hybrid-genome (Itaya et al, 2005) and the
S. cerevisiae clone containing a copy of the A. laidlawii
genome (Karas et al, 2012) have yet to yield useful new
phenotypes,theydoillustratecellularrobustnesstolarge-scale
genomic insertions. Studies that evaluate the effects of
swapping or refactoring essential operons will provide
information more directly relevant to evaluating the feasibility
of new designs. More generally, developments that further
combinesynthetic,semi-synthetic,andhybridapproacheswill
lead to deeper understanding of the limits of rational design
and optimization for engineered biological systems.
Testing and validation of engineered
genomes
Empirical testing and validation of modiﬁed and synthesized
genomes is necessary to determine whether the design goals
have been met. Applying high-throughput sequencing to
conﬁrm that a constructed genome matches its intended
sequence is one such crucial test. Although viability and
growth are also essential phenotypic tests, most design
objectives requirevalidation offunction through otherindirect
assays. Moreover, many genome construction approaches
result in libraries of different variants that require systematic
curation to identify and isolate the best genomes from the rest
of the population. Typical assays can be divided into low-
throughput and high-throughput screens, which identify
variants from populations of limited size (up to B10
5), and
high-throughput selections, which enable the isolation
of variants from much larger populations (Figure 5). For
example, validating a constructed genome sequence by high-
throughput sequencing is a form of low-throughput screen,
while a viability assay testing the ability to survive and
replicate underspeciﬁc conditions is a selection. In both cases,
the stringency of the assay is crucial, as constructs that do not
generate the desired phenotype but still pass the screen or
selection can lead to substantial delays and wasted effort.
Selections are considerably more powerful when it is possible
to generate large libraries of variants, as testing more variants
increases the likelihood of ﬁnding ones with the desired
phenotype.
Unfortunately, many desirable phenotypes cannot be
directly selected, including small-molecule biosynthesis and
other traits that are among the most frequent targets for
biological engineering. Low-throughput screens can generally
perform much more detailed phenotypic measurements
by employing microscopy, transcriptomics, proteomics, or
metabolomics to interrogate biological function at the cellular
level. As our ability to build large libraries of genome variants
grows, methods to increase the scale and throughput of such
phenotypic measurements toward high-throughput selections
will be urgently needed to isolate and validate engineered
genomes.
Genome-scale metabolic engineering
The application of genome-scale approaches to metabolic
engineering provides an excellent example of an integrated
platform that showcases the synthesis of rational design,
computational modeling, and multiplexed construction and
testing to tackle real-world biological engineering challenges.
Numerous studies have used metabolic engineering to modify
microbes to produce industrially relevant biochemicals and
biofuels such as ethanol (Ingram et al, 1998) and higher
alcohols (Atsumi et al, 2008), fatty acids (Steen et al, 2010),
amino acids (Leuchtenberger et al, 2005), shikimate precur-
sors (Bongaerts et al, 2001), terpenoids (Martin et al, 2003),
polyketides (McDaniel et al, 1999; Pfeifer et al, 2001), and
polymer precursors (e.g., 1,4-butanediol (Yim et al, 2011)).
A great example of genome-scale metabolic engineering is
Dupont’s near-decade long optimization of E. coli for
bioproduction of 1,3-propanediol (Nakamura and Whited,
2003). The industrially optimized strain required up to 26
genomic changes including insertions, deletions, and regula-
tory modiﬁcations. Recent advances in constraint-based
modeling (Lewis et al, 2012) have enabled in silico prediction
of genomic targets whose perturbation may enhance strain
performance or product yield. These computational predic-
tions are ripe for experimental validation using new genome
engineering tools. For example, OptKnock (Burgard et al,
2003), a computational tool that uses bi-level metabolic ﬂux
optimization to predict the phenotype of gene knockout
combinations, has been used to improve microbial production
of lactic acid (Fong et al, 2005). Deleting different combina-
tions of four identiﬁed genes (adhE, pta, pfk, glk)i nE. coli
signiﬁcantly improved secretion of the desired product.
Similarly,Alperetal(2005)describedasetofstrainsgenerated
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genomic targets that exhibited improved lycopene production
by up to 8.5-fold. More recently, Xu et al (2011) described the
use of genome-scale metabolic network modeling to generate
genetic modiﬁcations that enhanced production of the useful
precursor malonyl-CoA. Knockout and overexpression geno-
types inup to nine genes weregenerated combinatorially,with
some strains containing up to ﬁve modiﬁcations (triple
knockout, double overexpression).
Although these few studies suggest the promising potential
of higher-order mutants to access phenotypes needed to meet
challenging design goals, the experimental difﬁculty of
constructing such mutants has limited their use. The recent
development of multiplex genome-scale engineering tools
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generate combinatorial libraries of targeted mutations. We
have shown that combinatorial exploration of both translation
efﬁciencyand gene deletions in up to 24 genes can yield useful
combinations of genomic modiﬁcations for production of
lycopene (Wang et al, 2009). More recently, the MAGE
approach was extended to build a combinatorial library of
genomic variants that contained synthetic T7 promoters in up
to 12 genes involved in aromatic amino-acid biosynthesis
(Wang et al, 2012b). The combination of improved metabolic
models and new techniques enabling combinatorial explora-
tion and selection of speciﬁc genetic perturbations will
substantially accelerate metabolic engineering (Sandoval
et al, 2012).
Organismic genome engineering
When it comes to ease of designing, constructing, and testing
genomes, not all organisms are created equal. Some have
smaller genomes and unicellular lifestyles, while others have
larger genomes and undergo complex multicellular develop-
ment, both of which render genome design and modeling
difﬁcult. Some have many more tools available for genome
editing, while others are burdened with polyploid genomes
that increase the difﬁculty of constructing and testing new
designs. Some organismal phenotypes can be readily
measured, while others are subtle and hard to quantify.
Most importantly, some replicate in mere minutes and are
readily grown in large numbers, while others require years of
labor-intensive care to reach adulthood. The advent of new
technologies for genome design, construction, and testing
have compensated for some of these differences, but accen-
tuated the impact of others.
Dairy cows are classic examples of slow-growing, expen-
sive, multicellular organisms that nonetheless have a large
industryinvestedintheirimprovement.Whilecowshavebeen
modiﬁed through evolutionary engineering since antiquity,
their slow growth and large diploid genomes render them
recalcitrant to targeted variant construction and testing.
Furthermore, in silico predictive models of mammals do not
exist. Nevertheless, milk production has quadrupled over the
last60yearsbecausetheindustryrigorouslymeasuredoutputs
and applied extremely strong selection in the form of artiﬁcial
insemination (Funk, 2006). For decades, top bulls have
routinely sired tens of thousands of offspring, efﬁciently
transmitting only the best genes to the next generation—a
purely blind evolutionary search, but the most effective
strategy available given the constraints of the organism at
the time. Thanks to high-throughput sequencing, it is now
possible to design strategies to accelerate the rate of improve-
ment. Although we are far from understanding the mechan-
istic basis of milk production, recent genotyping sequencing
efforts have begun to identify the chromosomal regions and
individual genes favored by the past few decades of selection
(Larkin et al, 2012). The industry is now implementing
rationally designed generations-long strategies to hasten the
combination of known beneﬁcial alleles into single genomes
using selective breeding and perhaps, eventually, targeted
genome editing.
Microbes are the mirror image of domesticated animals in
almost every way. Unknown in antiquity due to their
microscopic size, they tend toward small haploid genomes
that can be grown quickly and in large numbers. Combined
withapowerfulselection,thesetraitspermitswiftevolutionary
engineering, as ﬁrst demonstrated by W.H. Dallinger’s nine-
teenth-century-directed evolution of microbial thermal toler-
ance from 181C to an astonishing 701C over 7 years (Dallinger,
1887). A dearth of screening and selection technologies
impeded further microbial engineering until the latter half of
the twentieth century, but the subsequent explosion of such
methods has rendered microbes—which combines rapid
growth, large population sizes, and powerful selections—the
organisms of choice for directed evolution studies. We recently
demonstrated that even smaller and faster-replicating genomes
can further accelerate and even automate evolutionary
engineering (Esvelt et al, 2011). Our system harnesses
ﬁlamentous phages, which require only minutes to replicate
in host E. coli cells, to optimize phage-carried exogenous genes
in a handful of days without researcher intervention. Com-
pounding their growth advantage is the fact that microbes and
phages are also ideal subjects for biological design, modeling,
targeted genome editing, and genome synthesis, all of which
can focus subsequent evolutionary searches on the regions of
sequence space most likely to encode desirable phenotypes.
Alternatively, these methods can compensate for the lack of a
powerful selection that precludes evolution. Future technolo-
gies will ideally extend some of the advantages enjoyed by
model organisms, such as E. coli and S. cerevisiae to other
organisms, enabling more genome engineering endeavors to
combine model-driven targeted manipulation with the best
growthandselectionparadigmavailabletothetargetorganism.
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biological chassis
One of the overarching goals of genome-scale engineering is to
develop insights and rules that govern biological design.
Unfortunately, most biological systems are riddled with
remnants of historically contingent evolutionary events—a
complex, highly heterogeneous state woefully unsuitable for
precise and rational engineering. Rational genome design
would be greatly facilitated by the construction of an under-
lying biological ‘chassis’ that is simple, predictable, and
programmable. From that foundation, we can begin to build
more complex systems that expand the repertoire of biochem-
ical capabilities and controllable parameters. Furthermore, the
chassis organism must contain mechanisms ensuring safe and
controlled propagation, with strong barriers preventing unin-
tended release into the environment and mechanisms that
genetically isolate it from other organisms. The chassis should
also contain obvious and permanent genetic signatures
of its synthetic origins for surveillance of its use and misuse.
Here we outline several classes of capabilities that should
serve as a framework for a ﬂexibly programmable biological
chassis (Figure 6). A combination of current and future
genome engineering technologies will be needed to construct
such an engineered system.
Reducing biological complexity
The difﬁculties inherent in designing living systems arise from
the vast number of cellular components and the sheer
complexity of their evolutionarily optimized network of
interactions. Simulating large numbers of heterogeneously
interacting molecules requires evaluating the probability and
magnitude of all possible interactions between non-identical
components, a task that would be computationally beyond us
even if we had perfect knowledge of every interaction (Koch,
2012).Westilldonotunderstandthefunctionofalmost20%of
the B4000 genes found in E. coli (Keseler et al, 2011). Given
that biological complexity is one of the most signiﬁcant
barriers to rational genome design, we should aim to build a
simpliﬁed microbial cell. Not only would such a cell serve as
an improved chassis for future engineering, the act of
constructing such a genome will transform our understanding
of the factors contributing to the performance, evolvability,
and robustness of cellular systems in general.
Single-gene deletion experiments (Giaever et al, 2002)
suggest that a signiﬁcant number of all genes are redundant,
with only B300 being individually essential (Feher et al,
2007). The ﬁrst step toward a simpliﬁed cellular chassis is to
reducethegenometoafunctionallyusefulsetofgenes.Several
groups have embarked upon endeavors to eliminate all
nonessential genes, starting with E. coli (Hashimoto et al,
2005; Posfai et al, 2006), B. subtilis (Ara et al, 2007), and
S. pombe (Giga-Hama et al, 2007). It is important to keep in
mind that whether a gene is essential depends on the
environmental conditions. Therefore, we deﬁne a set of useful
traits for a biological chassis as (1) fast growing in minimal
media with glucose, (2) capable of fermentation, (3) amenable
to genetic manipulation, and (4) minimally sufﬁcient such that
removal of any additional gene negatively affects the other
threestatedconsiderations. Acell containinga setofgenes that
satisfy the above criteria is said to have a core or minimal
chassis.AlthoughaviableE.coligenomewith20%fewergenes
has already been engineered (Posfai et al, 2006), it is likely that
a reduction of 50% is achievable for the core chassis. Even
though smaller genomes and simpler transcriptome do exist
(e.g., Mycoplasma pneumonia (Guell et al, 2009)), our core
chassis will be much more useful for biological engineering
because it will not suffer from slow growth or depend upon
additional exogenous metabolites. Moreover, engineering our
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Figure 6 Toward the construction of a ﬂexibly programmable chassis. Genome minimization reduces biological complexity and redundancy. Whole-genome codon
remapping enables orthogonal information encoding and expansion of the genetic code. De novo genome synthesis and reconstitution from natural genomes enables
creation of semi-synthetic and chimeric genomes with new and hybrid features. Whole-genome redesign and rewiring of regulatory systems enable new synthetic
circuitries that are easier to design and model.
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ally similar operons to facilitate future engineering.
With far fewer components and exponentially fewer
possible interactions, a cell with a core chassis will be much
more amenable to in silico modeling than wild-type E. coli or
even M. genitalium (Karr et al, 2012). Still, its remaining
components will interact in many more ways than we would
prefer, and not all of them are understood. This might be
remedied by reducing the number of regulatory interactions,
ideally by replacing endogenous regulatory elements with
well-deﬁned orthogonal equivalents. Temme et al (2012)
implementedthisconcept by‘refactoring’thenitrogen ﬁxation
cluster to remove all native gene regulation. Refactoring an
operon involves removing all non-coding DNA, nonessential
genes,and transcription factors,replacingessential geneswith
computer-designed synthetic genes recoded to eliminate
internal regulatory sites, and adding synthetic regulation.
Extending this approach to the entire core genome will be an
immense challenge, as each replacement must be optimized
withsyntheticcomponents.Ontheotherhand,cellulargrowth
and survival is a powerful and readily applicable selection,
enabling libraries of synthetic or rewired regulatory elements
to be quickly selected and sequenced to identify the best
performers(Isalanetal,2008).Minimizing thetotalnumberof
orthogonal regulatoryelements and compensating forchanges
in the expression of previously refactored operons caused by
adding additional binding sites are likely to be the most
challenging aspects of the project. Adding additional but well-
deﬁned levels of regulation such as orthogonal 16S ribosomes
(Rackham and Chin, 2005), synthetic ZF transcription factors
(Khalil et al, 2012), or orthogonal RNA-based translational
repressors (Isaacs et al, 2004) may be necessary to increase
growthto acceptable levelswhile minimizing thetotal number
of components.
A ﬁnal challenge concerns the effects of natural selection on
our simpliﬁed genome. We expect our rationally designed
synthetic chassis to be suboptimal, in that simple growth in
glucose media may lead to accumulation of beneﬁcial
mutations. Careful tracking of these beneﬁcial mutations as
theyoccur will simplify the task of decoding the newly created
interactions and reveal important design ﬂaws in our in silico
models. Only by understanding and attempting to compensate
forthesenewinteractionswillwelearnhowtofurthersimplify
and optimize the performance of our engineered system.
Orthogonal information encoding
A frequent objection to the use of genetically modiﬁed
organisms is the possibility of unintended consequences
arising from accidental release. Improved methods for
biological containment would reduce such risks while raising
public awareness of beneﬁcial genome engineering research.
One such containment strategyis the development of a chassis
thatutilizesanorthogonalgeneticcode(Isaacsetal,2011).The
canonical encoding scheme maps 64 possible codons to 20
corresponding amino acids and three stop signals. Except for a
few known organisms (Knight et al, 2001), the genetic code is
the single most well-preserved property in all of biology and
thought to be irreversibly ﬁxed in its current conﬁguration as a
result of ‘the frozen accident’ (Crick, 1968). Acodon-swapped
organism might have codons that are normally assigned to
leucine instead encode arginine. Although the resulting
protein sequence would not change, the encoded nucleotide
sequences would be quite different in a recoded organism
compared with the wild type. Achieving this goal would
involve not only recoding of all genes in the new genomic
chassis, but would also require minor alterations to the
anticodon sequences of tRNAs to accommodate different
codon swaps. A combination of genome synthesis and
engineering will be needed to realize such an endeavor.
More importantly, a radically recoded chassis would be
unable to productively exchange genetic material with other
organisms in the environment. When transferred into a wild-
type cell, recoded genes from a swapped-codon chassis will
generate meaningless proteins due to mistranslation from
reassigned codons. Conversely, natural geneswill not function
in the swapped-codon chassis, preventing our synthetic
genome from becoming contaminated with wild toxins,
pathogenicity elements, or antibiotic resistance genes. Indeed,
genetic isolation from all other domains of life will also confer
broad immunity to natural viruses, a signiﬁcant advantage
for the industrial-scale production of biochemicals. However,
the recoded chassis may still interact with the physical
environment and with other organisms indirectly via nutri-
tional exchange and space competition. These aspects present
opportunities for further rational engineering. Finally, recoded
organisms will contain many genomic signatures of their
synthetic origin, allowing easy identiﬁcation and surveillance
of their origin, make, and purpose in comparison to natural
variants.
Expanded biochemical repertoire
With the exception of post-translational modiﬁcations in
higher-level organisms, the amino-acid repertoire of cells is
mostly conﬁned to the canonical 20 amino acids. Unnatural
amino acids have been successfully incorporated into proteins
using several strategies involving orthogonally evolved tRNA
and tRNA synthetases (Hendrickson et al, 2004; Xie and
Schultz, 2005), but this approach has been hampered by lower
efﬁciencies of incorporation due to competition with existing
codon recognition factors (Young et al, 2010). Expanding the
repertoire of possible amino acids that the cell can use to build
proteins is a powerful capability that will be readily available
to any recoded chassis. Unnatural amino acids will dramati-
cally expand the biochemical repertoire of cells by enabling
new chemistries that are inaccessible to natural systems
(Liu and Schultz, 2010). Whole-genome recoding can readily
free up codons by reducing the degeneracy of the current
codon mapping. New amino acids can be assigned to ‘free
codons’ as long as the existing proteins are recoded with the
synonymous codons to retain the amino-acid sequence. A
similar event occurred when a handful of organisms began to
encode the 21st amino acid, selenocysteine, with the TGA
codon that functions as a STOP codon in other forms of life
(Forchhammer et al, 1989). Although eliminating signiﬁcant
numbers of rare sense codons may be challenging, the
prospect of engineering a ﬂexible chassis with the ability to
encodemultiple unnaturalaminoacidsandaccessphenotypes
unavailable to natural organisms is worth the attempt.
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Thus far, we have only considered methods for engineering
individual genomes in the laboratory. Similar and related
techniques might be adapted to modify most or all of the
individual genomes that together constitute a single species:
the pan-genome. There are important safety and ecological
considerations to assess before attempting any such project.
Nevertheless, the environmental impact of human activity has
already effected vast changes across the genomes of a large
fractionofspeciesallacrossEarth.Itmaybeworthconsidering
approaches that might correct such problems and accomplish
desirable changes in a more benign manner. For example, we
might spread a modiﬁcation conferring drought resistance
through the many local cultivars of a crop plant, with each
cultivar retaining its local adaptations and genetic diversity.
Such an approach would likely be superior in yield and lower
in ecological impact to one in which all such variants are
replaced with monocultures cloned from a single laboratory-
modiﬁed plant. Similarly, human disease vectors such as
mosquitoes might be engineered to resist pathogen transmis-
sion, which would be considerably cheaper and more
ecologically friendly than heavy insecticide use. Several
genome engineering tools might be used to address these
challenges. Targeting the wild-type locus with nucleases
would catalyze DSB repair using the transgenic cassette as a
template, effectively converting all heterozygotes to homo-
zygotes. Conceptually similar ‘gene-drives’ have proven
effective in the laboratory (Windbichler et al, 2011). Alter-
natively, a site-speciﬁc recombinase targeted to the wild-type
locus could exchange the ends of homologous chromosomes,
moving the desired modiﬁcation to the formerly wild-type
chromosome and leaving behind a toxin rendering the donor
chromosome sterile. Unlike other methods, this approach
could be limited to a ﬁnite number of ‘jumps’ by placing a
limited numberof recombination sites and toxins on the initial
donor, thereby improving our control over the spread of the
engineered genetic element. Meanwhile, traitsmight be driven
through microbiomes by combining horizontal gene transfer
mechanisms with transposon- or retrotransposon-mediated
gene insertion. Further advances in these areas scaled to the
ecosystem level (Mee and Wang, 2012) may extend our
genome engineering capabilities across the pan-genome,
although we emphasize that ecological and safety considera-
tions should be thoroughly assessed before such technologies
are deployed.
Concluding remarks
Recent technological advances have overcome many of the
limitations and bottlenecks that have constrained genome-
scale engineering. The exponential decrease in cost of DNA
sequencing has dramatically accelerated forward genomics
while enabling sequence conﬁrmation of synthesized and
edited genomes. New methods are bringing down the cost of
DNA synthesis at an even faster rate. Emerging technologies
for gene insertion, multiplex editing, and large fragment
assembly have dramatically expanded our capabilities
in certain model organisms, but further enhancements and
extensiontootherorganismsandacrossspecieswillbeneeded
to extend our engineering capabilities to the ecological level.
Similarly, improvedin silico modeling capabilities areurgently
needed to guide rational genome design and synergize
productively with evolutionary optimization. Finally, we
suggest that the construction of a ﬂexibly programmable
biological chassis may serve as a foundation and standard for
synthetic biology. These and other ambitious endeavors will
continue to challenge our capabilities as genome engineers
and our competence as biological designers.
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